Clinical trial
OmegAD (Omega-3 and Alzheimer's Disease)
NCT00211159 · Karolinska University Hospital, Other · Completed
Key facts
| NCT number | NCT00211159 |
|---|---|
| Title | OmegAD (Omega-3 and Alzheimer's Disease) |
| Official title | Omega-3 Fatty Acid Treatment of 174 Patients With Mild to Moderate Alzheimer's Disease (OmegAD): a Randomized Double-blind Trial |
| Lead sponsor | Karolinska University Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | EPAX 1050TG |
| Enrollment | 204 |
| Start date | Dec 1, 2000 |
| First posted | Sep 21, 2005 |
| Last update posted | Jul 31, 2017 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: